Elon Musk Slams "Drug Use" Claims - Fires Back at NYTimes Allegations!

Elon Musk recently found himself in the spotlight following allegations made by the *New York Times* that suggested he was involved in using drugs such as ketamine, ecstasy, and hallucinogenic mushrooms. In response, Musk has openly disputed these claims. He took to X (formerly Twitter) to firmly deny the accusations and characterized the *New York Times'* report as misleading . He did acknowledge having tried ketamine a few years ago under medical prescription to navigate challenging times, but emphasized that he has not used it since. These statements were made shortly after a press conference held with Donald Trump, where he further refuted the claims .

Elon Musk has fervently denied recent allegations from the *New York Times* accusing him of using drugs, including ketamine and ecstasy. In a tweet on X, Musk stated emphatically that he does not consume drugs, dismissing the claims as falsehoods propagated by the media. This came right after a press conference where he reiterated his stance, saying, "I do not take illegal drugs," and challenged the integrity of the reports. The allegations, which suggested a habitual usage pattern, have been countered by Musk's admission of only using ketamine in controlled, prescribed doses during tough times, an exploration into alternative therapies rather than recreational use. [Read more about Musk's clear stance](https://www.journaldemontreal.com/2025/05/31/je-ne-prends-pas-de-drogues-sindigne-elon-musk).

These declarations by Musk arose amidst a significant event—his joint press conference with former President Donald Trump—where he was accompanied by Trump himself, who praised Musk's achievements and downplayed the accusations as frivolous distractions. The pairing of these influential figures highlighted the intersection of public and political manœuvrings, as Musk managed to steer the attention towards his entrepreneurial successes and leadership roles. While publicly defending himself, Musk's tactfulness in handling such controversial matters was on full display, showing his prowess in navigating the press and public perception. [Discover more about the event](https://www.journaldemontreal.com/2025/05/31/je-ne-prends-pas-de-drogues-sindigne-elon-musk).

In the wake of these allegations, the public reaction has been conspicuously mixed, with social media platforms like X buzzing with diverse opinions. Some supporters staunchly defend Musk, ridiculing the accusations as mere fabrications or media witch-hunts, while others express skepticism, citing his admitted past use of ketamine and the peculiar timing of the accusations. This polarity echoes across forums and online debates, with discussions intensified over Musk's lifestyle choices influencing his executive decisions. Regardless of the divided opinion, Musk's proactive engagement in addressing these allegations showcases his commitment to transparency and accountability. [Check further public discussions](https://www.hindustantimes.com/world-news/us-news/elon-musk-breaks-silence-on-new-bombshell-drug-abuse-charge-netizens-react).

The controversy and its handling could have lasting implications for Musk's broader aspirations, especially those overlapping with governmental and business interests. As Musk continues to negotiate these complex dynamics, questions about his eligibility and character inevitably arise, potentially impacting contracts and collaborations with governmental entities. Such situations demand diligent crisis management, a field Musk is quite familiar with but also highlight the underlying risks associated. Further exploration into how these allegations might impact his future endeavors remains imperative. [Explore related implications](https://time.com/7290129/elon-musk-drug-use-trump-oval-office/).

The recent allegations made by the *New York Times* against Elon Musk have generated considerable media attention and public debate. The report accused Musk of using drugs such as ketamine, ecstasy, and hallucinogenic mushrooms, claims which Musk vehemently denied. On his social media platform, X (previously known as Twitter), Musk accused the newspaper of fabricating stories, emphatically stating that he does not indulge in drugs. Instead, Musk acknowledged a past instance where he used ketamine 'on prescription' for personal reasons but clarified that he no longer uses it. These statements followed a widely-publicized press conference with former President Donald Trump, where he further dismissed the allegations. The full report can be found here.

The *New York Times* report, published just a day before Musk's public denial, highlighted these serious allegations, sparking reactions from different sectors. During a press conference alongside Donald Trump, Musk criticized the newspaper's claims, casting doubt on the integrity of the publication. The timing of the report's release, prior to a weekend, perhaps added to the sensational nature of the news, amplifying its coverage across various media outlets. Further insights into the initial allegations indicate Musk's alleged frequent use of these substances, contributing to significant public interest and debate over the authenticity of these claims. To read more on the subject, visit the original news URL at Journal de Montreal.

In the wake of the *New York Times* report, reactions have been varied, particularly from figures in politics and business. Donald Trump's public praise of Elon Musk, in the same breath as dismissing the drug allegations, reflects the complicated dynamics influencing public opinion. These interactions notably influence investor confidence, particularly in Tesla's performance, given the market's historical sensitivity to Musk's personal and professional conduct. For more on the potential interconnected business impacts, relevant discussions can be found in detailed analytical commentaries here.

Expert opinions add depth to the conversation, especially regarding the implications of Musk's reported ketamine use. Toxicologist Dr. Ryan Marino and social worker Shari B. Kaplan have elaborated on the potential health impacts of chronic ketamine use, such as bladder complications, which are more prevalent with frequent dosage. While Musk denies regular use, these expert analyses provide context to evaluate the accuracy of the *New York Times* claims. The detailed expert opinions illustrate the broader conversation surrounding responsible drug use, further explored here.

Social media continues to be a battlefield for discussions about Musk and the *New York Times* report. Public reactions have ranged from supportive defenses to skeptical critiques, with users dissecting Musk's responses and the implications of his past drug use assertions. The polarizing nature of the discourse underscores the unpredictability of public figures navigating personal controversies in the digital age. Insights into the gamut of public opinions and their socio-political ramifications are discussed at length here.

Donald Trump, known for his bold defense of allies, did not hold back in defending Elon Musk amid the swirling drug allegations reported by the *New York Times*. During a press conference, Trump staunchly supported Musk, asserting that the tech mogul's accomplishments transcend any baseless accusations made against him. Trump hailed Musk's innovative spirit and emphasized his belief in Musk's integrity and character, dismissing the allegations as attempts to vilify a visionary leader. Trump's unwavering backing of Musk during this controversy underscores their complex and often discussed relationship, further exemplified by Trump's previous praise for Musk’s achievements at companies like Tesla and SpaceX [source](https://www.foxbusiness.com/markets/elon-musks-return-drives-tesla-stock-surge-may).

The public's reaction to the allegations against Elon Musk has been as polarized as expected given Musk's prominent public figure status. On platforms like X (formerly Twitter), conversations and debates erupted, with some users firmly standing by Musk, accusing the *New York Times* report of being a baseless attack on a successful entrepreneur. Many supporters expressed their unwavering faith in Musk’s statements, labeling the allegations as mere distractions from his pivotal work. Conversely, skeptics seized upon Musk's past admissions of ketamine use to question his credibility, despite his vehement denial of any current drug use. Online discussions reflected a broader societal divide, blending skepticism, support, and a hint of humor over the idea of Musk's alleged drug escapades. In essence, the public reaction is a testament to Musk's polarizing influence as both a business leader and a social media figure [source](https://www.hindustantimes.com/world-news/us-news/elon-musk-breaks-silence-on-new-bombshell-drug-abuse-charge-netizens-react-its-funny-that-101748693716582.html).

Elon Musk's statements regarding drug use have often been met with intense scrutiny and widespread discussion, particularly given his prominent public position. In a recent denial, Musk firmly rejected allegations made by the *New York Times* that he uses drugs like ketamine, ecstasy, and hallucinogenic mushrooms. Reiterating his stance on X (formerly Twitter), Musk accused the media outlet of dishonesty and maintained that he does not partake in such substances. He did, however, admit to having been prescribed ketamine years ago to help navigate challenging periods, though he insists that this usage was short-lived and regulated ().

Musk's denial is not without context. In a press conference alongside Donald Trump, Musk dismissed these drug accusations, underscoring the nature of his limited ketamine use. Trump, during this conference, also came to Musk's defense, highlighting Musk's innovation and leadership without directly addressing the allegations ().

Public and expert opinions vary widely on this topic. While some support Musk's innovative spirit and relate his assertive denials to his unique personality, others remain skeptical due to Musk's previous admissions of using ketamine for personal reasons. Experts have commented that the usage pattern described in the media report could potentially lead to significant health issues, contradicting Musk's claim of minimal and past usage ().

Amidst Musk's denials, a dynamic landscape of public opinion has emerged. While some factions view the allegations as a targeted smear against Musk’s character, fueled by media sensationalism, others entertain the possibility of truth due to Musk’s eccentric persona and past statements about drug use. The viral discussions highlight the polarized and complex public relationship with Musk, as his mention of ketamine, despite its legal prescription status, invites a broad spectrum of interpretations and assumptions ().

Elon Musk's emphatic denial of drug allegations by The New York Times has echoed across the media landscape, drawing significant attention to his companies, including Tesla. Amidst these claims, which Musk refuted both online and in a press conference alongside Donald Trump, Tesla's stock market performance offered insights into the potential impacts of these controversial news. Despite Musk's return as CEO sparking a 22% surge in Tesla stock in May 2025, as noted in a report by Fox Business [0](https://www.foxbusiness.com/markets/elon-musks-return-drives-tesla-stock-surge-may), the ripple effects of the drug allegations, albeit denied, could still cast shadows over investor sentiment and stock stability. Concerns over Musk's leadership capabilities and credibility have the potential to incite market volatility, reflecting the broader impacts on other Musk-owned enterprises like SpaceX and X (formerly Twitter). For Tesla and these other ventures, the ability to weather this storm will rely heavily on robust crisis management and sustained assurances to stakeholders that the company's strategic vision remains undeterred.

The dialogue around Elon Musk and the alleged drug use allegations has sparked various reactions, with significant implications for the companies he leads. Public perceptions can impact Musk's roles as a visionary leader and prominent social media personality, potentially affecting his influential presence on X (formerly Twitter). As public trust and the narrative surrounding his personal life evolve, his sway over societal and economic facets may alter, as noted by multiple public reactions [0](https://opentools.ai/news/elon-musks-alleged-drug-days-in-the-trump-era-face-scrutiny). While some experts suggest this could lead to a decline in his influence unless effectively managed, analysts at The Guardian have highlighted ongoing lawsuits involving Musk and his companies that could further influence public perception [1](https://www.theguardian.com/us-news/2025/may/22/ftc-media-matters-x-investigation). The mixture of legal challenges and public scrutiny could pose significant operational hurdles for his businesses, demanding strategic negotiation through complex socio-political terrains."

Politically, the scandal involving allegations of drug use could redefine Elon Musk's relationships with key political figures and entities. His former engagement in a government role and ties with political figures such as Donald Trump are instances where personal controversy may intersect with professional endeavors [0](https://www.foxbusiness.com/markets/elon-musks-return-drives-tesla-stock-surge-may). The repercussions could manifest in strained relationships or impact his capacity to influence policy, as highlighted by coverage from sources like Vanity Fair [1](https://www.vanityfair.com/news/elon-musk-black-eye-donald-trump-oval-office). The complexity of Musk's public persona and business interests, particularly in a politically charged environment, underscores the potential for altered dynamics in his dealings with governmental and regulatory bodies. These shifts might augment existing legal and bureaucratic challenges, demanding adept maneuvering to safeguard his and his companies’ interests moving forward.

Social media plays a crucial role in shaping public perception, especially when it comes to high-profile individuals like Elon Musk. Musk's denial of drug use allegations by the *New York Times* illustrates how social media platforms can serve as a battleground for public opinion. By taking to X (formerly Twitter) to categorically deny these claims, Musk utilized his vast social media reach to influence public discourse directly [0](https://www.journaldemontreal.com/2025/05/31/je-ne-prends-pas-de-drogues-sindigne-elon-musk). This strategy highlights the dual-edged sword of social media presence—while it offers a platform for immediate rebuttal and narrative control, it also opens individuals to heightened scrutiny and debate among users.

The political landscape surrounding Elon Musk is as dynamic as ever, especially given the recent drug use allegations published by the *New York Times*. Musk's outspoken denial of these allegations, particularly at a press conference where he stood alongside Donald Trump, adds another layer of complexity to his already intricate political relationships. His association with Trump, a figure often embroiled in his own controversies, further accentuates the political implications of these allegations . As Musk continues to navigate these waters, the way he handles the allegations will likely influence his political alliances and his ability to wield influence within governmental spheres.

The long-term consequences and expert opinions regarding Elon Musk's denial of drug use allegations are multifaceted, with significant implications in various spheres. The allegations, which were strongly refuted by Musk during a joint press conference with Donald Trump, revolve around claims by the *New York Times* that Musk used drugs like ketamine, ecstasy, and hallucinogenic mushrooms . While Musk has admitted to using ketamine "on prescription" in the past, he vehemently denies current usage which brings about discussions on both his character and leadership.

Experts like Dr. Ryan Marino and Shari B. Kaplan have raised concerns about the potential health impacts of chronic drug use. They emphasize that frequent ketamine usage, such as that described by unnamed sources in the *New York Times*, can lead to serious bladder issues . The veracity of these claims, weighed by experts against Musk’s own statements, continues to fuel a contentious debate regarding the health implications if any of the alleged claims were true.

Public and expert opinion on Musk’s alleged drug use is divided, with some expressing distrust in the media’s portrayal and others concerned about Musk's personal credibility and its potential fallout. The public reaction has ranged from staunch support of Musk to skepticism about the media’s motives . The controversy, coupled with the potential impact on Musk's influential role as a leading tech entrepreneur, continues to stir both social media and financial markets.

This controversy unfolds at a critical time when Musk's various business ventures, including Tesla, SpaceX, and X, face intense scrutiny from investors and regulatory bodies. The economic impacts of allegations, even if unsubstantiated, might be felt in fluctuating stock prices and investor confidence, potentially exacerbating existing challenges in the highly competitive technological and automotive landscapes . How smoothly Musk can navigate through these allegations may dictate the future trajectory of Musk-owned enterprises.

In the political arena, Musk’s associations, particularly with influential figures like Donald Trump and his past role within the Department of Government Efficiency, could see strain as he attempts to sidestep the ongoing accusations . The interplay between his business interests and political engagements may have far-reaching consequences on his ability to maintain pivotal roles in the future. His experience underscores the fine line walked by entrepreneurs with political affiliations amid personal controversies.

In summary, the allegations against Elon Musk regarding drug use have sparked widespread debate and dissection of his public and personal narratives. The media frenzy surrounding these claims, especially given Musk's towering presence in the technological and entrepreneurial landscape, illustrates the precarious balance between celebrity and scandal. Despite Musk's vigorous denials, which he vocalized both on social media platforms like X and in the presence of former President Donald Trump, the implications of these allegations may reverberate beyond immediate public perception.

Critics question whether this controversy will permanently tarnish Musk's image as a visionary leader, or if it will serve as yet another storm that he weathers amidst his storied career. The allegations, if persisting in public discourse, could potentially alter stakeholder perceptions, from investors in Tesla to participants within the broader ecosystem of Musk’s enterprises. These sentiments hold particular weight given that Tesla had recently experienced a robust surge in its stock value upon Musk's return as CEO, a testament to the intertwined nature of his personal and professional spheres. [See more on Tesla stock increase]('https://www.foxbusiness.com/markets/elon-musks-return-drives-tesla-stock-surge-may').

Furthermore, the broader social and political ramifications remain to be seen. Public trust in Musk, and by extension, in the companies he leads, could face tests under the steady scrutiny of press and stakeholders. Existing legal battles, including those surrounding X and Media Matters, only add layers to the unfolding narrative. As Musk navigates through these waters, the dynamics of public opinion, legal challenges, and his strategic responses will be pivotal in shaping the future landscape for him and his ventures.

Elon Musk's trajectory in the coming months will likely be watched closely, not just by industry insiders but by a captivated general audience eager to see how this saga unfolds. Will Musk's denials and strategic maneuvers suffice to eclipse claims of misconduct, or will this episode usher in a new chapter with reevaluated perceptions and realigned loyalties? Only time will tell how Musk, armed with a resolute denial of drug use accusations, steers through these questions, balancing his formidable influence against the weight of public judgment.

Ultimately, the resolution of this controversy—or its endurance—will hinge on the interplay of public perception, legal proceedings, and Musk's direct engagement with stakeholders and audiences. Whether these allegations prove to be a pivotal chapter in Musk’s narrative or just another incident in the high-profile life of a modern innovator, the conclusion at this juncture remains open to interpretation.